Cajal Therapeutics
1 known investors
Cajal Therapeutics develops small molecule and RNA medicines aimed at restoring iron homeostasis to treat serious conditions such as anemias of inflammation, neurodegenerative diseases, and other iron-related disorders. Its lead program, CTX001, is an iron mobilizer designed to restore iron transport.
BiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Cajal Therapeutics do?
- Cajal Therapeutics develops small molecule and RNA medicines aimed at restoring iron homeostasis to treat serious conditions such as anemias of inflammation, neurodegenerative diseases, and other iron-related disorders. Its lead program, CTX001, is an iron mobilizer designed to restore iron transport.
- Who are Cajal Therapeutics's investors?
- Cajal Therapeutics's investors include The Column Group.